We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $21.7B
1-Year Est. Return 30.58%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+30.58%
3 Year Est. Return
+82.67%
5 Year Est. Return
+103.42%
10 Year Est. Return
+340.42%
AUM
$21.7B
AUM Growth
+$1.85B
Cap. Flow
-$80.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
29.3%
Holding
349
New
22
Increased
85
Reduced
186
Closed
8

Top Buys

Rank Stock Value
1
APO icon
Apollo Global Management
APO
+$134M
2
UNH icon
UnitedHealth
UNH
+$108M
3
CMI icon
Cummins
CMI
+$86.1M
4
TKO icon
TKO Group
TKO
+$72.8M
5
HUBB icon
Hubbell
HUBB
+$69.8M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$175M
2
LMT icon
Lockheed Martin
LMT
+$126M
3
PEP icon
PepsiCo
PEP
+$98.6M
4
AVGO icon
Broadcom
AVGO
+$90.2M
5
XOM icon
ExxonMobil
XOM
+$89.5M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 16.18%
3 Healthcare 13.51%
4 Industrials 13.35%
5 Energy 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
176
Enbridge
ENB
$110B
$5.29M 0.02%
97,647
-28,162
-22% -$1.54M
OTIS icon
177
Otis Worldwide
OTIS
$27.3B
$5.18M 0.02%
72,367
-5,960
-8% -$445K
CAT icon
178
Caterpillar
CAT
$368B
$5.17M 0.02%
4,859
-19
-0.4% -$16.7K
MSA icon
179
Mine Safety
MSA
$7.34B
$4.92M 0.02%
28,163
-22,884
-45% -$3.83M
VLO icon
180
Valero Energy
VLO
$101B
$4.76M 0.02%
18,294
-200
-1% -$49.2K
TTEK icon
181
Tetra Tech
TTEK
$9.36B
$4.47M 0.02%
154,884
-106,073
-41% -$3.11M
ENTG icon
182
Entegris
ENTG
$20.6B
$4.47M 0.02%
+24,829
New +$3.58M
ORCL icon
183
Oracle
ORCL
$435B
$4.37M 0.02%
29,833
-15,396
-34% -$2.79M
DUK icon
184
Duke Energy
DUK
$93.8B
$4.21M 0.02%
33,283
+509
+2% +$64.2K
DCI icon
185
Donaldson
DCI
$10.7B
$3.75M 0.02%
41,800
NYT icon
186
New York Times
NYT
$11B
$3.71M 0.02%
53,069
-33,036
-38% -$2.55M
MKTX icon
187
MarketAxess Holdings
MKTX
$5.73B
$3.6M 0.02%
31,678
-948
-3% -$135K
MOG.A icon
188
Moog Inc Class A
MOG.A
$11.9B
$3.36M 0.02%
+7,932
New +$2.71M
DGX icon
189
Quest Diagnostics
DGX
$26.8B
$3.32M 0.02%
15,665
-1,476
-9% -$290K
ISRG icon
190
Intuitive Surgical
ISRG
$132B
$3.28M 0.02%
8,244
-310
-4% -$135K
MS icon
191
Morgan Stanley
MS
$337B
$3.26M 0.02%
15,590
+83
+0.5% +$16.4K
JKHY icon
192
Jack Henry & Associates
JKHY
$12.1B
$3.16M 0.01%
22,917
-2,676
-10% -$380K
AMAT icon
193
Applied Materials
AMAT
$366B
$3.05M 0.01%
4,217
-453
-10% -$209K
IBM icon
194
IBM
IBM
$222B
$3.04M 0.01%
10,820
-109
-1% -$27.5K
LRCX icon
195
Lam Research
LRCX
$378B
$3.04M 0.01%
7,020
+870
+14% +$264K
VEA icon
196
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.92M 0.01%
41,028
-334
-0.8% -$23.3K
GS icon
197
Goldman Sachs
GS
$301B
$2.9M 0.01%
2,868
-50
-2% -$48.7K
NSC icon
198
Norfolk Southern
NSC
$78.3B
$2.86M 0.01%
9,076
MDT icon
199
Medtronic
MDT
$117B
$2.82M 0.01%
36,082
-2,969
-8% -$240K
MO icon
200
Altria Group
MO
$115B
$2.82M 0.01%
39,136
+363
+0.9% +$25.3K

Similar funds

Bahl & Gaynor's Q2 2026 Portfolio in Review

As of Q2 2026, Bahl & Gaynor held 349 positions worth $21.7B, up 9.3% from $19.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bahl & Gaynor's Q2 2026 filing shows 22 new, 85 increased, 186 reduced and 8 closed positions. Its largest new stake was TKO Group: 373,391 shares worth $75.2M. The largest sale was Johnson & Johnson, an estimated $175M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q2 2026 buy was TKO Group: 373,391 shares worth $75.2M.
  • Bahl & Gaynor added most to Apollo Global Management in Q2 2026, an estimated $134M increase.
  • Bahl & Gaynor's biggest Q2 2026 reduction was Johnson & Johnson, cutting an estimated $175M.
  • Bahl & Gaynor fully exited Oshkosh in Q2 2026, selling an estimated $8.49M.
  • Bahl & Gaynor's ten largest holdings make up 29% of its $21.7B portfolio in Q2 2026.
  • Bahl & Gaynor opened 22 new positions and closed 8 in Q2 2026.
  • Bahl & Gaynor's portfolio value rose 9.3% quarter-over-quarter to $21.7B.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.